Martin Shkreli, Supreme Court
Supreme Court Snubs Martin Shkreli’s Last-Ditch Bid to Avoid $64 Million Fine
There were no generic alternatives to a lifesaving drug when Shkreli jacked up its price by more than $700 per pill in 2015.
Shkreli Bid to Overturn $65 Million Daraprim Award Rejected by Supreme Court
The US Supreme Court left in place a $65 million antitrust judgment against Martin Shkreli, the “Pharma Bro” who served almost seven years in prison for defrauding investors.
Supreme Court rejects appeal from ‘Pharma Bro’ Martin Shkreli
The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the price of a lifesaving drug.
U.S. Supreme Court Rejects Martin Shkreli's Appeal
The former pharmaceutical executive sought to appeal a $64.6 million judgement issued against him for inflating drug cost and trying to stifle generics from launching.
Supreme Court Snubs Martin Shkreli's $64.6 Million Appeal
The U.S. Supreme Court refused to hear Martin Shkreli's appeal against a $64.6 million penalty imposed for steeply raising a drug's price. The penalty was equivalent to profits made from the price hike of Daraprim in 2015,
Supreme Court Denies Shkreli’s $64M Disgorgement Rehearing
The U.S. Supreme Court declined on Monday to review former pharmaceutical executive Martin Shkreli's challenge to a $64 million disgorgement order, which was imposed after his alleged scheme to raise the price of a life-saving drug by 4,
US Supreme Court rejects 'Pharma Bro' Martin Shkreli's appeal of penalties
The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug's price by more than 4,
Supreme Court Denies Shkreli's $64.6 Million Penalty Appeal
The Supreme Court declined to hear Martin Shkreli's appeal against a $64.6 million penalty for raising a drug's price by over 4,000%. The penalty corresponds to profits from raising Daraprim's price and includes a lifetime ban from the drug industry.
Supreme Court rejects Martin Shkreli fine appeal
The Supreme Court on Monday rejected a bid by notorious 'pharma bro' Martin Shkreli to hear his appeal of a $64 million financial penalty on the fraudster. Shkreli had been ordered to pay that penalty for blocking competition to a life-saving drug whose price he had raised by more than $700 per pill.
US Supreme Court rejects ex-pharma CEO Martin Shkreli's appeal
The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug's price by more than 4,
Supreme Court rejects ‘Pharma Bro’ Martin Shkreli’s appeal of $65M in penalties
The judge cited Shkreli’s “particularly heartless and coercive” tactics in monopolizing Daraprim and keeping generic rivals off the market.
SCOTUS denial ends saga of Shkreli’s infamous 5,000% drug price scheme
The legal saga over Martin Shkreli's infamous 5,000 percent price hike of a life-saving anti-parasitic drug has ended with a ...
Martin Shkreli can't escape his $64 million fine
The U.S. Supreme Court decided on Monday not to take up Martin Shkreli’s appeal of a $64.6 million penalty he received after ...
Martin Shkreli Admits It’s ‘Highly Likely’ Many People Have Copies of Wu-Tang Clan’s One-Copy-Only Album
Martin Shkreli admitted he doesn’t know how many people have copies of the Wu-Tang Clan’s one-copy-only album 'Once Upon a ...
‘Pharma Bro’ Martin Shkreli’s appeal rejected by Supreme Court
Martin Shkreli an order to return millions in profits he and his former company reaped after monopolizing the market for a ...